Verity Asset Management’s Meridian Bioscience Inc VIVO Stock Holding History

Verity Asset Management’s Portfolio VIVO Stock Details VIVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-23,758	Closed	-$418K	–	138
2019 Q1	$418K	Buy	23,758 +2,473	+12%	+$41.1K	0.48%	63
2018 Q4	$370K	Sell	21,285 -3,260	-13%	-$55.6K	0.5%	56
2018 Q3	$366K	Sell	24,545 -2,793	-10%	-$43.3K	0.36%	71
2018 Q2	$435K	Buy	27,338 +6,339	+30%	+$94.6K	0.39%	47
2018 Q1	$298K	Buy	20,999 +10,732	+105%	+$159K	0.27%	72
2017 Q4	$161K	Buy	+10,267	New	+$150K	0.12%	125
2017 Q2	–	Sell	-14,332	Closed	-$198K	–	148
2017 Q1	$198K	Buy	+14,332	New	+$200K	0.16%	112
2016 Q3	$254K	Buy	13,170 +2,401	+22%	+$47K	0.24%	85
2016 Q2	$210K	Buy	+10,769	New	+$211K	0.21%	88

Other funds holding VIVO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

SFM

Systematic Financial Management Teaneck, New Jersey $4.36B AUM 40.56% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Verity Asset Management's VIVO Position: Q2 2019 in Review

Verity Asset Management sold out of Meridian Bioscience Inc (VIVO) in Q2 2019, closing a stake of 23,758 shares — an estimated $418K sold.

Verity Asset Management first reported a position in VIVO in Q2 2016 and held it in 9 quarters. The position peaked at $435K in Q2 2018. 173 funds tracked by Wall St. Rank hold VIVO as of Q2 2019.

Verity Asset Management reported no remaining Meridian Bioscience Inc position as of Q2 2019 after selling out during the quarter.
Verity Asset Management sold 23,758 Meridian Bioscience Inc shares in Q2 2019, an estimated $418K.
Verity Asset Management first reported a position in Meridian Bioscience Inc in Q2 2016 and held it in 9 quarters.
Verity Asset Management's Meridian Bioscience Inc position peaked at $435K in Q2 2018.
173 funds tracked by Wall St. Rank held Meridian Bioscience Inc as of Q2 2019.

Based on Verity Asset Management's 13F filing for Q2 2019, filed 6 Aug 2019.